نتائج البحث من 91 إلى 100 من أصل 1810 لعبارة anti-TNF drugs
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
Translational Neuropathology Melissa E Murray.
Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...
Others find tumor cells and help kill them or transmit tumor killing molecules to them. It is not yet known whether radiation therapy is more effective when ...
... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... treatment until disease progression or 2 years since treatment ... anti-PD(L)1 ...
... treatment in patients with treatment-naive ALK-positive advanced NSCLC. Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg ...
... Therapy Treatment for a Brain Tumor. Rochester, Minn. This phase III trial compares memantine to usual treatment in treating patients with brain tumors that ...
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
... anti-T-cell immunoglobulin and ITM domain (TIGIT) ... Chemotherapy drugs, such as capecitabine and ... Giving atezolizumab with usual treatment may work better than ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.